6,7-Dehydroroyleanone diterpene derived from Tetradenia riparia essential oil modulates IL-4/IL-12 release by macrophages that are infected with Leishmania amazonensis
The treatment of cutaneous leishmaniasis in associated with several adverse effects and therapeutic failure, resulting in patients’ abandonment of treatment. Research on new drugs with leishmanicidal potential from medicinal plants is essential. The anti-Leishmania activity of Tetradenia riparia essential oil (TrEO) and its derivatives, such as the diterpene 6,7-dehydroroyleanone (TrROY), and the immunomodulatory effects of TrEO have been reported. However, few studies have investigated the effects of TrROY. The present study evaluated the modulation of cytokine production by murine macrophages that were infected with Leishmania amazonensis (6 parasites/macrophage) and treated with TrROY (0.1, 1, and 100 μg/ml). Cytokine levels were measured by flow cytometry. The results were analyzed using Student’s t test at a 95% confidence interval. Microscopic counting was performed to evaluate the inhibitory effects of TrROY on intracellular infection. TrROY modulated the production of cytokines that are essential for the immune defense response to Leishmania, with a decrease in interleukin-4 (IL-4) levels and an increase in IL-12 levels. A TrROY concentration of 0.1 μg/ml was chosen for the subsequent experiments. This dose was chosen because it modulated IL-4/IL-12 release by murine macrophages that were infected with Leishmania and because it presented no cytotoxic effects. TrROY (0.1 μg/ml) induced a 31% reduction of the rate of infection in murine macrophages compared with untreated cells. TrROY may be a promising leishmanicidal agent. Further in vitro and in vivo studies should be conducted to evaluate the anti-Leishmania and immunomodulatory activity of TrROY.
Keywords6,7-Dehydroroyleanone diterpene Tetradenia riparia essential oil Leishmania amazonensis
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Brazil, supported this work.
Compliance with ethical standards
This study was approved by the Committee of Ethics in Animal Use in Experiments (CEAE) of the State University of Maringá (Paraná, Brazil; opinion nos. 133/2012 and 079/2012) to obtain cells from BALB/c mice.
Conflict of interest
The authors declare that there is no conflict of interest.
- Baldin VP, Bertin De Lima Scodro R, Lopes-Ortiz MA, et al (2018) Anti-Mycobacterium tuberculosis activity of essential oil and 6,7-Dehydroroyleanone isolated from leaves of Tetradenia riparia (Hochst.) Codd (Lamiaceae). Phytomedicine in press. doi: https://doi.org/10.1016/j.phymed.2018.04.043, 47, 34, 39CrossRefPubMedGoogle Scholar
- Brazil (2017) Manual for surveillance of cutaneous leishmaniasis. Publisher of the Ministry of HealthGoogle Scholar
- Demarchi IG, Thomazella MV, de Souza Terron M, Lopes L, Gazim ZC, Cortez DAG, Donatti L, Aristides SMA, Silveira TGV, Lonardoni MVC (2015b) Antileishmanial activity of essential oil and 6,7-dehydroroyleanone isolated from Tetradenia riparia. Exp Parasitol 157:128–137. https://doi.org/10.1016/j.exppara.2015.06.014 CrossRefPubMedGoogle Scholar
- Gazim ZC, Amorim AC, Hovell AMC et al (2010) Seasonal variation, chemical composition, and analgesic and antimicrobial activities of the essential oil from leaves of Tetradenia riparia (Hochst.) Codd in southern Brazil. Molecules 15:5509–5524. https://doi.org/10.3390/molecules15085509 CrossRefPubMedPubMedCentralGoogle Scholar
- Gazim ZC, Rodrigues F, Amorin ACL, Rezende C, Soković M, Tešević V, Vučković I, Krstić G, Cortez L, Colauto N, Linde G, Cortez D (2014) New natural diterpene-type abietane from Tetradenia riparia essential oil with cytotoxic and antioxidant activities. Molecules 19:514–524. https://doi.org/10.3390/molecules19010514 CrossRefPubMedGoogle Scholar
- Herbert DR, Orekov T, Roloson A, Ilies M, Perkins C, O'Brien W, Cederbaum S, Christianson DW, Zimmermann N, Rothenberg ME, Finkelman FD (2010) Arginase I suppresses IL-12/IL-23 p40-driven intestinal inflammation during acute schistosomiasis. J Immunol 184:6438–6446. https://doi.org/10.4049/jimmunol.0902009 CrossRefPubMedPubMedCentralGoogle Scholar
- Vendrame CMV, Carvalho MDT, Rios FJO, Manuli ER, Petitto-Assis F, Goto H (2007) Effect of insulin-like growth factor-I on Leishmania amazonensis promastigote arginase activation and reciprocal inhibition of NOS2 pathway in macrophage in vitro. Scand J Immunol 66:287–296. https://doi.org/10.1111/j.1365-3083.2007.01950.x CrossRefPubMedGoogle Scholar
- World Health Organization (2010) Control of the leishmaniases: report of a meeting of the WHO Expert Committee on the Control of Leishmaniasis. WHO Tech Rep Ser 949:22–26. https://goo.gl/6iYa7H. Accessed 5 Jan 2018